Biotech IPOs Reward Investors Keeping Window Wide Open
Not only has the window for biotech initial public offerings (IPOs) remained wide open so far this year, but also the after-market performance of the newly minted public companies has been nothing short of amazing – recording a collective 68 percent increase in share price after hitting the markets. Not surprising then that companies on the biotech IPO runway have been anxious to take flight.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST